Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY AnalysisPeter Rossing, Duncan J. Topliss, Stefan D. Anker et al.|Diabetes Care|2022Cited by 207
Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trialHiddo J.L. Heerspink, Bi‐Cheng Liu, Rajiv Agarwal et al.|Nephrology Dialysis Transplantation|2024Cited by 83
Finerenone in Patients With Chronic Kidney Disease Due to Glomerular DiseasesBrendon L. Neuen, Gina Campestri, K R Tuttle et al.|JAMA|2026Cited by 5